From Casetext: Smarter Legal Research

United Therapeutics Corp. v. Liquidia Techs.

United States Court of Appeals, Federal Circuit
Oct 10, 2024
No. 2024-1658 (Fed. Cir. Oct. 10, 2024)

Opinion

2024-1658

10-10-2024

UNITED THERAPEUTICS CORPORATION, Plaintiff-Appellant v. LIQUIDIA TECHNOLOGIES, INC., Defendant-Appellee


This order is nonprecedential.

Appeal from the United States District Court for the District of Delaware in No. 1:20-cv-00755-RGA, Judge Richard G. Andrews.

Before PROST, HUGHES, and CUNNINGHAM, Circuit Judges.

ON MOTION

ORDER

PER CURIAM

United Therapeutics Corporation moves to dismiss the above-captioned appeal pursuant to Fed. R. App. P. 42(b) with each side to bear its own costs.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted.

ISSUED AS A MANDATE: October 10, 2024.


Summaries of

United Therapeutics Corp. v. Liquidia Techs.

United States Court of Appeals, Federal Circuit
Oct 10, 2024
No. 2024-1658 (Fed. Cir. Oct. 10, 2024)
Case details for

United Therapeutics Corp. v. Liquidia Techs.

Case Details

Full title:UNITED THERAPEUTICS CORPORATION, Plaintiff-Appellant v. LIQUIDIA…

Court:United States Court of Appeals, Federal Circuit

Date published: Oct 10, 2024

Citations

No. 2024-1658 (Fed. Cir. Oct. 10, 2024)